Agoraphobia Resource Center
Home Definition Symptoms Treatments FAQs Articles Research Resources

Agoraphobia Research

Alprazolam (Xanax) and exposure for panic disorder with agoraphobia. Attribution of improvement to medication predicts subsequent relapse. The British Journal of Psychiatry, Volume 164, 1994, Pages 652-659.

M. Basoglu, I.M. Marks, C. Kilie, C. R. Brewin and RP Swinson; Institute of Psychiatry, Denmark Hill, London.

Summary:

In an experimental study, patients with panic disorder with agoraphobia underwent eight weeks of drug treatment (Xanax or a placebo) and psychological treatment (exposure or relaxation). At the end of treatment, patients who had improved were asked to rate how much their improvement had to do with medication or their own effort.

Patients who attributed their improvement to their own effort were more likely to maintain improvement after an eight week period of tapering off medication and at follow-up (after 43 weeks of no treatment). Patients who attributed their improvement to medication were more likely to relapse, especially among those who took the Xanax and not the placebo.

The conclusion of the study is that what you attribute your recovery to may have consequences. If you recover from agoraphobia its best to attribute recovery to your own efforts. But if you think it was the Xanax that did it, you will probably prove yourself right.

back to research
home           
                         

 
Subscribe to Our Newsletter!

Name

Email



The Agoraphobia Report is the electronic newsletter devoted to your freedom, relaxation and peace of mind.

Receive insightful articles,
summaries of the latest research
and recovery tips.

Join our FREE newsletter today!

More Info?            Privacy Statement